These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10464436)

  • 1. Grading impairment in leprosy.
    van Brakel WH; Reed NK; Reed DS
    Lepr Rev; 1999 Jun; 70(2):180-8. PubMed ID: 10464436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring impairment caused by leprosy: inter-tester reliability of the WHO disability grading system.
    Nienhuis WA; van Brakel WH; Butlin CR; van der Werf TS
    Lepr Rev; 2004 Sep; 75(3):221-32. PubMed ID: 15508899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of impairment scores following commencement of chemotherapy in multibacillary leprosy patients.
    Reed NK; van Brakel WH; Reed DS
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):328-36. PubMed ID: 9401485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring impairment in leprosy: choosing the appropriate tool.
    Ebenso J; Ebenso BE
    Lepr Rev; 2007 Sep; 78(3):270-80. PubMed ID: 18035778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hand-foot impairment score as a tool for evaluating prevention of disability activities in leprosy: an exploration in patients treated with corticosteroids.
    Broekhuis SM; Meima A; Koelewijn LF; Richardus JH; Benbow C; Saunderson PR
    Lepr Rev; 2000 Sep; 71(3):344-54. PubMed ID: 11105494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO disability grading: operational definitions.
    Brandsma JW; Van Brakel WH
    Lepr Rev; 2003 Dec; 74(4):366-73. PubMed ID: 14750582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-rater reliability of WHO 'disability' grading.
    Brandsma W; Larsen M; Richard C; Ebenezer M
    Lepr Rev; 2004 Jun; 75(2):131-4. PubMed ID: 15282963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of physical impairments in leprosy patients: a comparison between the world health organization (who) disability grade and the Eye-Hand-Foot score.
    Raposo MT; Caminha AV; Heukelbach J; Sánchez-González MÁ; de Medeiros JL; Nemes MI
    Rev Inst Med Trop Sao Paulo; 2011; 53(2):77-81. PubMed ID: 21537754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of impairment during and after treatment: the AMFES cohort.
    Meima A; Saunderson PR; Gebre S; Desta K; Habbema JD
    Lepr Rev; 2001 Jun; 72(2):158-70. PubMed ID: 11495447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field evaluation of WHO-MDT of fixed duration at ALERT, Ethiopia: the AMFES project--I. MDT course completion, case-holding and another score for disability grading.
    de Rijk AJ; Gabre S; Byass P; Berhanu T
    Lepr Rev; 1994 Dec; 65(4):305-19. PubMed ID: 7861917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leprosy-related disabilities after release from multidrug treatment: prevalence and spatial distribution].
    Nardi SM; Paschoal Vdel A; Chiaravalloti-Neto F; Zanetta DM
    Rev Saude Publica; 2012 Dec; 46(6):969-77. PubMed ID: 23358621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome.
    Saunderson P; Gebre S; Desta K; Byass P; Lockwood DN
    Lepr Rev; 2000 Sep; 71(3):285-308. PubMed ID: 11105488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Social Determinants of Health and Disability Scores in Leprosy-Affected Persons in Salem, Tamil Nadu, India.
    Heidinger M; Simonnet E; Karippadathu SF; Puchinger M; Pfeifer J; Grisold A
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with impairments in new leprosy patients: the AMFES cohort.
    Meima A; Saunderson PR; Gebre S; Desta K; van Oortmarssen GJ; Habbema JD
    Lepr Rev; 1999 Jun; 70(2):189-203. PubMed ID: 10464437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability grading in leprosy: current status.
    Thappa DM
    Indian J Lepr; 1994; 66(3):299-306. PubMed ID: 7861044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society.
    Menaldi SL; Harini M; Nelfidayani N; Irawati Y; Setiono S; Wahyuni LK; Rahayu T; Andayani G; Friska D; Nugraha B
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010646. PubMed ID: 35984857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.
    Richardus JH; Finlay KM; Croft RP; Smith WC
    Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment and disability in leprosy: in search of the missing link.
    van Brakel WH; Anderson AM
    Indian J Lepr; 1997; 69(4):361-76. PubMed ID: 9474512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.